Outcomes for Absorb stent acceptable at 1 to 2 years, with caveats
Patients receiving the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS), a dissolving stent to open clogged vessels around the heart, showed outcomes comparable with patients receiving the Xience drug-eluting ...
Mar 20, 2017
0
0